Also worthy of mention is the August 5 date for an FDA decision on Pennsaid for NRI.TO, NRIFF.PK (.353)
I know it's a grey sheet company, but the volumes have been robust lately. It has dropped from the 52 week high of a week ago, but with such a large float and convertibles paid out at .12, it's easy to see why some would cash in before the decision date.
Covidien bet 10 miilion large on approval. I'm in for a smaller piece of the action, lol.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.